Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Corti

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Microbiology Spectrum|June 25, 2015
Efficient Methods To Isolate Human Monoclonal Antibodies from Memory B Cells and Plasma CellsDavide Corti, Antonio Lanzavecchia
Annual Review of Immunology|January 22, 2013
Broadly neutralizing antiviral antibodiesDavide Corti, Antonio Lanzavecchia
Current Opinion in Immunology|March 21, 2016
Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious diseaseDavide Corti, Jeffrey D Kearns
Current Opinion in Virology|May 9, 2018
Viral envelope-specific antibodies in chronic hepatitis B virus infectionDavide Corti, Fabio Benigni, Daniel Shouval
Current Opinion in Immunology|May 24, 2011
High throughput cellular screens to interrogate the human T and B cell repertoiresDavide Corti, Federica Sallusto, Antonio Lanzavecchia
Current Opinion in Biotechnology|December 8, 2007
Human monoclonal antibodies by immortalization of memory B cellsAntonio Lanzavecchia, Davide Corti, Federica Sallusto
Journal of Infection and Public Health|April 23, 2016
Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndromeDavide Corti, Nadia Passini, Antonio Lanzavecchia, et al.
Current Opinion in Immunology|June 26, 2016
Antibody-guided vaccine design: identification of protective epitopesAntonio Lanzavecchia, Alexander Frühwirth, Laurent Perez, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Closing coronavirus spike glycoproteins by structure-guided designMatthew McCallum, Alexandra C Walls, Davide Corti, et al.
Cell|June 4, 2021
Tackling COVID-19 with neutralizing monoclonal antibodiesDavide Corti, Lisa A Purcell, Gyorgy Snell, et al.
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Microbiology Spectrum|June 25, 2015
Efficient Methods To Isolate Human Monoclonal Antibodies from Memory B Cells and Plasma CellsDavide Corti, Antonio Lanzavecchia
Annual Review of Immunology|January 22, 2013
Broadly neutralizing antiviral antibodiesDavide Corti, Antonio Lanzavecchia
Current Opinion in Immunology|March 21, 2016
Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious diseaseDavide Corti, Jeffrey D Kearns
Current Opinion in Virology|May 9, 2018
Viral envelope-specific antibodies in chronic hepatitis B virus infectionDavide Corti, Fabio Benigni, Daniel Shouval
Current Opinion in Immunology|May 24, 2011
High throughput cellular screens to interrogate the human T and B cell repertoiresDavide Corti, Federica Sallusto, Antonio Lanzavecchia
Current Opinion in Biotechnology|December 8, 2007
Human monoclonal antibodies by immortalization of memory B cellsAntonio Lanzavecchia, Davide Corti, Federica Sallusto
Journal of Infection and Public Health|April 23, 2016
Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndromeDavide Corti, Nadia Passini, Antonio Lanzavecchia, et al.
Current Opinion in Immunology|June 26, 2016
Antibody-guided vaccine design: identification of protective epitopesAntonio Lanzavecchia, Alexander Frühwirth, Laurent Perez, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Closing coronavirus spike glycoproteins by structure-guided designMatthew McCallum, Alexandra C Walls, Davide Corti, et al.
Cell|June 4, 2021
Tackling COVID-19 with neutralizing monoclonal antibodiesDavide Corti, Lisa A Purcell, Gyorgy Snell, et al.
Pageof 21